On the contrary, the expression of TCN1 was significantly lower than that in normal control tissues in lymphoid neoplasm diffuse large B cell lymphoma (DLBC), breast invasive carcinoma (BRCA), liver hepatocellular carcinoma (LIHC), testicular germ cell tumors (TDCT), acute myeloid leukemia (LAML), and head and neck squamous cell carcinoma (HNSC) (Fig. 1a). This evidence concerns the gene TCN1 and diffuse large B-cell lymphoma.